TG Therapeutics Financial Health
How is TG Therapeutics's financial position?
Financial Health Score3/6
Financial Health Score 3/6
Short Term Liabilities
Long Term Liabilities
Stable Cash Runway
Forecast Cash Runway
Financial Position Analysis
Short Term Liabilities: TGTX's short term assets ($182.9M) exceed its short term liabilities ($36.4M).
Long Term Liabilities: TGTX's short term assets ($182.9M) exceed its long term liabilities ($81.0M).
Debt to Equity History and Analysis
Debt Level: TGTX has more cash than its total debt.
Reducing Debt: TGTX's debt to equity ratio has increased from 0.2% to 69.8% over the past 5 years.
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: TGTX has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if TGTX has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.